Table 4.

Comparisons among ESBL-positive cases

Characteristics of the cases	Discordant empirical treatment (n=18)	Concordant empirical treatment (n=10)	p
Age Mean.±SD (year)	66.8±13.8	71.2±13.8	0.424
Gender, n (%)
Female	7 (38.9)	3 (30.0)	0.703
Male	11 (61.1)	7 (70.0)
Admission complaint, n (%)
Fever	17 (94.4)	9 (90.0)	1.000
Confusion	3 (16.7)	2 (20.1)	1.000
Dysuria	5 (27.8)	4 (40.0)	0.677
Flank pain	5 (27.8)	3 (30.0)	1.000
Vomiting	10 (55.6)	4 (40.0)	0.430
History
Hospitalization within the last 3 months	9 (50.0)	4 (40.0)	0.705
Antibiotic use within the last 10 days	7 (38.9)	1 (10.0)	0.194
Physical examination
Tachycardia (100 bpm)	9 (50.0)	5 (50.0)	1.000
Tachypnea (>24/min)	5 (27.8)	4 (40.0)	0.677
Hypotension (SKB<90)	3 (16.7)	0 (0)	0.533
Costovertebral angle tenderness	4 (22.2)	6 (60.0)	0.097
Suprapubic tenderness	4 (22.2)	0 (0)	0.265
Complicating factors
Urolithiasis	2 (11.1)	0 (0)	0.524
Urinary system malignancies	3 (16.7)	0 (0)	0.533
Benign prostatic hyperplasia	0 (0)	1 (10.0)	0.357
Nephrostomy	1 (5.6)	1 (10.0)	1.000
Neurogenic bladder	1 (5.6)	0 (0)	1.000
Indwelling catheterization	1 (5.6)	0 (0)	1.000
Intermittent catheterization	0 (0)	0 (0)
Diabetes mellitus	7 (38.3)	2 (20.0)	0.417
Laboratory parametres
Pyuria	17 (94.4)	10 (100)	1.000
Leucocyte, median	13490	16687	0.338
Neutrophil, median	11833.9	13996	0.533
Platelet, median	232777.8	231400	0.968
Hemoglobin, median	11.1	12.1	0.268
CRP, median	208.4	220.1	0.749
Hospital stay (days) Mean±SD	12.7±5.2	12.0±7.4	0.765
Health state at discharge n (%)
Cure	16 (88.9)	9 (90.0)	1.000
Referral to ICU	1 (5.6)	0 (0)
Death	1 (5.6)	1 (10.0)

SS: standard deviation; ESBL: extended–spectrum beta-lactamase; SBP: Systolic blood pressure; CRP: C-reactive protein; ICU: intensive care unit